The Efficacy and Safety of BioBlock® Intranasally Administered Virus-Neutralizing Bovine Colostrum Nasal Spray in Preventing of COVID-19 (Coronavirus Disease-19) Infection in Healthy Volunteer Individuals

PHASE4UnknownINTERVENTIONAL
Enrollment

2,000

Participants

Timeline

Start Date

May 1, 2022

Primary Completion Date

July 31, 2023

Study Completion Date

December 30, 2023

Conditions
SARS CoV 2 Infection
Interventions
BIOLOGICAL

BioBlock® antiviral nasal spray

SARS-CoV-2 BioBlock is a natural preparation derived from bovine colostrum, where animals have an immune response against the SARS-CoV-2 spike protein in addition to conventional vaccines. The antiviral colostrum preparation was made from colostrum of cows immunized with SARS CoV-2 spike protein. Pregnant cows were immunized during the third trimester of gestation using a non-infectious recombinantly produced and purified SARS CoV-2 spike protein. Colostrum, which is milked after calving, concentrates most of the antibodies produced in the cow's body at very high concentrations, including neutralizing antibodies to SARS CoV-2 produced as a result of immunization.

Trial Locations (1)

Unknown

RECRUITING

AS Chemi-Pharm, Tallinn

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Chemi-Pharm AS

INDUSTRY